| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/22/2004 | US20040077653 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders |
| 04/22/2004 | US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 04/22/2004 | US20040077644 Administering quinoline derivative as analgesic |
| 04/22/2004 | US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 04/22/2004 | US20040077641 Insecticides for crops |
| 04/22/2004 | US20040077633 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
| 04/22/2004 | US20040077626 In vivo stability; very low metabolism rate |
| 04/22/2004 | US20040077625 Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake |
| 04/22/2004 | US20040077525 Novel treatment |
| 04/22/2004 | CA2501803A1 Thiazole compounds for the treatment of neurodegenerative disorders |
| 04/22/2004 | CA2501611A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/22/2004 | CA2501575A1 Inhibitors of fatty acid amide hydrolase |
| 04/22/2004 | CA2501491A1 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
| 04/22/2004 | CA2501352A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
| 04/22/2004 | CA2500582A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/21/2004 | EP1411055A1 Thiazolidinedione derivative and its use as antidiabetic |
| 04/21/2004 | EP1411054A1 Thiazolidinedione derivative and its use as antidiabetic |
| 04/21/2004 | EP1411047A1 Intercalators having affinity for DNA and methods of use |
| 04/21/2004 | EP1410822A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 04/21/2004 | EP1410799A1 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 04/21/2004 | EP1409546A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 04/21/2004 | EP1409525A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 04/21/2004 | EP1409484A1 Substituted benzo-nitro-heterocycles |
| 04/21/2004 | EP1409481A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 04/21/2004 | EP1409477A1 Piperidine derivatives as nmda receptor antagonists |
| 04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1252159B1 Method for producing heterocyclic compounds |
| 04/21/2004 | EP1149094B1 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 04/21/2004 | EP0964860B1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | EP0877736B1 Benzazepine derivatives with vasopressin agonistic activity |
| 04/21/2004 | CN1491224A 5-[4-[2(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salt |
| 04/21/2004 | CN1491218A Method for preparing compounds derived from thiazolidinedione, oxazolidinedione |
| 04/21/2004 | CN1146575C Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 04/21/2004 | CN1146568C Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 04/21/2004 | CN1146564C Antibiotic sultam and sultone drived oxazolidiones |
| 04/21/2004 | CN1146560C Substituted benzoylpyrazoles as herbicides |
| 04/21/2004 | CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/20/2004 | US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent |
| 04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
| 04/20/2004 | US6723741 Benzimidazoles and benzothiazoles and uses thereof |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723722 Acylhydrazine derivatives, their production and use |
| 04/20/2004 | US6723720 Pesticidal triazine-derivatives |
| 04/20/2004 | US6723718 Substituted α, β-anellated butyrolactones |
| 04/20/2004 | CA2215585C Practical synthesis of urea derivatives |
| 04/15/2004 | WO2004031401A2 Novel tyrosine kinases inhibitors |
| 04/15/2004 | WO2004031384A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | WO2004031184A1 4,6-diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors |
| 04/15/2004 | WO2004031183A1 Novel modification of the compound 4-hydroxy-2-methyl-n-(5-methyl-2-thiazolyl)-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide in the form of a crystalline acetic acid solvate and use thereof as a medicament |
| 04/15/2004 | WO2004031181A1 Sulfonamide derivatives as antipsychotic agents |
| 04/15/2004 | WO2004031179A1 Indole-3-carboxamides as glucokinase (gk) activators |
| 04/15/2004 | WO2004031174A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/15/2004 | WO2004031172A1 Piperidine derivatives as ccr5 inhibitors |
| 04/15/2004 | WO2004031158A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 04/15/2004 | WO2004031154A1 Novel lactams and uses thereof |
| 04/15/2004 | WO2004030637A2 Treatment of obesity and other disorders associated with excessive food intake |
| 04/15/2004 | WO2004030440A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 04/15/2004 | WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 04/15/2004 | WO2003045324A3 14-methyl-epothilones |
| 04/15/2004 | WO2003022844A9 Synthesis of epothilones intermediates thereto and analogues thereof |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040073029 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072876 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 04/15/2004 | US20040072871 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them |
| 04/15/2004 | US20040072870 Anticancer agents |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072849 Dioxanes and uses thereof |
| 04/15/2004 | US20040072838 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 04/15/2004 | US20040072829 Piperazinyltriazines as estrogen receptor modulators |
| 04/15/2004 | US20040072828 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 04/15/2004 | US20040072827 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 04/15/2004 | US20040072825 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy) ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof |
| 04/15/2004 | US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases |
| 04/15/2004 | US20040072692 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines |
| 04/15/2004 | US20040072252 Heteroaryl substituted benzothiazole dioxetanes |
| 04/15/2004 | DE10257188B3 Preparation of meso-substituted cyanine dye, for radiation-sensitive coating, e.g. for making printing plate, printed circuit boards or DVD, from 2-halo-cyclo-pentene or -hexene-dianil involves 1-stage introduction of end and meso-groups |
| 04/15/2004 | CA2501243A1 Piperidine derivatives as ccr5 inhibitors |
| 04/15/2004 | CA2500883A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | CA2500056A1 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 04/15/2004 | CA2495698A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/14/2004 | EP1407782A1 Preventives/remedies for organ functional disorders and organ dysfunction |
| 04/14/2004 | EP1406900A1 Novel compounds, their preparation and use |
| 04/14/2004 | EP1406899A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 04/14/2004 | EP1406898A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/14/2004 | EP1406897A2 Compounds |
| 04/14/2004 | EP1406893A1 Pyrrolidine bicyclic compounds |
| 04/14/2004 | EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |